Evaluate the Safety and Tolerability of a Single-dose Administration of BMI2004 Inj.
Clinical trial NCT05922813 · COMPLETED
Trial details
- NCT number
- NCT05922813
- Sponsor
- BMI Korea
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2023-03-10
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.